[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340413-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340413-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","bidirectional-signals-generated-by-siglec-7-and-its-crucial-ligand-tri-sialylated-t-to-escape-of-cancer-cells-from-immune-surveillance","Bidirectional signals generated by Siglec-7 and its crucial ligand tri-sialylated T to escape of cancer cells from immune surveillance","","Siglec-7 is an inhibitory receptor on NK cells that recognizes sialic acid–containing glycans, yet its ligand glycan structures and carrier proteins were not fully defined. The study identifies four sialyltransferases and two O-glycan carrier proteins, PODXL and MUC13, using colon cancer cells, showing that ligand binding reduces immune-cell cytotoxicity while activating cancer cells to enhance invasion. Mass spectrometry reveals a tri-sialylated T antigen ligand glycan, supporting a bidirectional signaling mechanism that enables cancer escape from immune surveillance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/bidirectional-signals-generated-by-siglec-7-and-its-crucial-ligand-tri-sialylated-t-to-escape-of-cancer-cells-from-immune-surveillance/340413/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/bidirectional-signals-generated-by-siglec-7-and-its-crucial-ligand-tri-sialylated-t-to-escape-of-cancer-cells-from-immune-surveillance/340413.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What bidirectional signals are generated when Siglec-7 binds its ligand?","Question",{"text":63,"@type":64},"Binding of Siglec-7 ligand glycans delivers inhibitory signals to Siglec-7–expressing immune cells, reducing cytotoxic activity, while activating cancer cells to enhance invasion activity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which ligand glycan and carrier proteins are identified for Siglec-7?",{"text":68,"@type":64},"The ligand structure is revealed as a tri-sialylated T antigen. PODXL and MUC13 are identified as ligand O-glycan-carrier proteins, and podoplanin (PDPN) is used to reveal the ligand glycan structure.",{"name":70,"@type":61,"acceptedAnswer":71},"How do the identified sialyltransferases relate to cancer prognosis?",{"text":72,"@type":64},"Sialyltransferase genes involved in synthesizing the Siglec-7 ligand are reported to be associated with poor prognosis in cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340413,1790146581,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","iScience  \nll  \nOPEN ACCESS  \nArticle  \nBidirectional signals generated by Siglec-7 and its crucial ligand tri-sialylated T to escape of cancer cells from immune surveillance  \nNoboru Hashimoto, Shizuka Ito, Akira Harazono, ..., Yasusei Kudo, Nana Kawasaki, Koichi Furukawa  \n[koichi@isc.chubu.ac.jp](koichi@isc.chubu.ac.jp)  \nHighlights  \nSiglec-7 inhibits cytotoxicity via the molecules identiﬁed as ligand glycan-carrier  \nThe molecules enhance metastatic property of cancer cell by binding of Siglec-7  \nSialyltransferase genes that synthesize the ligand relate a poor prognosis in cancer  \nThe ligand structure is revealed to be a tri-sialyl T antigen  \nHashimoto et al. , iScience 27, 111139  \nNovember 15, 2024 ª 2024 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/](https://doi.org/10.1016/)[ ](https://doi.org/10.1016/)[j.isci.2024.111139](j.isci.2024.111139)  \niScience  \nll  \nOPEN ACCESS  \nArticle  \nBidirectional signals generated by Siglec-7 and its crucial ligand tri-sialylated T  \nto escape of cancer cells from immune surveillance  \nNoboru Hashimoto, 1,2 Shizuka Ito,1 Akira Harazono,3 Akiko Tsuchida,4 Yasuhiro Mouri,5 Akihito Yamamoto,2 Tetsuya Okajima, 1 Yuhsuke Ohmi,6 Keiko Furukawa,7 Yasusei Kudo,5 Nana Kawasaki,8 and Koichi Furukawa 1,7,9,*  \nSUMMARY  \nSiglec-7, an inhibitory receptor expressed on natural killer (NK) cells, recognizes sialic acid-containing glycans. However, the ligand glycan structures of Siglec-7 and its carrier proteins have not been comprehensively investigated. Here, we identiﬁed four sialyltransferases that are used for the synthesis of ligand glycans of Siglec-7 and two ligand O-glycan-carrier proteins, PODXL and MUC13, using a colon cancer line. Upon binding of these ligand glycans, Siglec-7-expressing immune cells showed reduced cytotoxic activity, whereas cancer cells expressing ligand glycans underwent signal activation, leading to enhanced invasion activity. To clarify the structure of the ligand glycan, podoplanin (PDPN) identiﬁed as a Siglec-7 ligand-carrier protein, was transfected into HEK293T cells using sialyltransferase cDNAs. Mass spectrometry of the products revealed a ligand glycan, tri-sialylated T antigen. These results indicate that Siglec-7 interaction with its ligand generates bidirectional signals in NK and cancer cells, leading to the efﬁcient escape of cancers from host immune surveillance.  \nINTRODUCTION  \nSiglecs, a family of sialic acid-recognizing lectins, are mainly expressed on the cell surface of immune cells.1 Most Siglecs have an immunoreceptor tyrosine-based inhibitory/switch motif (ITIM/ITSM) in the cytosol. These motifs undergo tyrosine phosphorylation by Src family kinase.2 Binding of the ligand glycans promotes receptor phosphorylation and transduction of an inhibitory signal into Siglec-expressing cells.3–7 To date, 15 family members of Siglecs have been reported in humans and 9 family members in mice. Siglecs belong to the immunoglobulin superfamily and are divided into the Siglec-1, 2, 4, and 15, which are widely conserved in mammals, and the Siglec-3 subfamily, the details of which vary depending on the species. Siglec-7 belongs to the human Siglec-3 subfamily. The extracellular domain is characterized by having a V-set domain that recognizes sialic acids.8  \nAlthough the Siglecs have been shown to be involved in regulation of the immune reaction, it has also been reported that they are used as tools for infection by bacteria and viruses. As for cancer cells, we already reported that Siglec-9 enhances motility and invasion of astrocytoma cells. Siglec-9 expressed on monocytes activates calpain in cancer cells that express ligand glycans, inactivates cell adhesion molecules, and induces adhesion dynamics.9 However, there are no deﬁnite reports on the escape of cancer cells from host immune surveillance based on the bidirectional signals, that is, inhibitory signals into immune cells and activation signals into cancer cells.  \nSiglec-7 i","cbCaij2rASmZj1N3","https://ap.wps.com/l/cbCaij2rASmZj1N3","pdf",6790919,25,"English","# SUMMARY\n# INTRODUCTION","[{\"question\":\"What bidirectional signals are generated when Siglec-7 binds its ligand?\",\"answer\":\"Binding of Siglec-7 ligand glycans delivers inhibitory signals to Siglec-7–expressing immune cells, reducing cytotoxic activity, while activating cancer cells to enhance invasion activity.\"},{\"question\":\"Which ligand glycan and carrier proteins are identified for Siglec-7?\",\"answer\":\"The ligand structure is revealed as a tri-sialylated T antigen. PODXL and MUC13 are identified as ligand O-glycan-carrier proteins, and podoplanin (PDPN) is used to reveal the ligand glycan structure.\"},{\"question\":\"How do the identified sialyltransferases relate to cancer prognosis?\",\"answer\":\"Sialyltransferase genes involved in synthesizing the Siglec-7 ligand are reported to be associated with poor prognosis in cancer.\"}]","Bidirectional signals generated by Siglec-7 and its crucial ligand tri-sialylated T to escape of cancer cells from immune surveillance | PDF",1790036358,63,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89b94739975e088e92d00e6069738c38.webp",983,1276,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fb368ba14f138fd28c833adce71aec2.webp",982,1275,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b852a7c9bef260dc2fe49e9b40a36957.webp",981,1273,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0b7c983d6db415f6803cef9b76446eb.webp",980,1272]